Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the President's Cancer Panel.
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
The meeting will closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended, because the premature disclosure of information and the discussions would likely to significantly frustrate implementation of recommendations.
Name of Committee: President's Cancer Panel.
Date: November 1-2, 2004.
Open: November 1, 2004, 8 a.m. to 4 p.m.
Agenda: Translating Research to Reduce Burden of Cancer.
Place: The Frank E. Anderson Conference Hall, MD Anderson Cancer Center, University of Texas, Houston, Texas 77030.
Closed: November 2, 2004, 9 a.m. to 12 p.m.
Agenda: To review and evaluate prepublication manuscripts on Translating Research into Clinical Practice.
Place: The Frank E. Anderson Conference Hall, MD Anderson Cancer Center, University of Texas, Houston, Texas 77030.
Contact Person: Maureen O. Wilson, PhD, Executive Secretary, National Cancer Institute, National Institutes of Health, 31 Center Drive, Building 31, Room 3A18, Bethesda, MD 20892, 301/496-1148.
Any interested person may file written comments with the committee by forwarding the comments to the Contact Person listed on this Notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/advisory/pcp/pcp.htm,, where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS.)
Dated: September 29, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-22406 Filed 10-5-04; 8:45 am]
BILLING CODE 4140-01-M